Xometry (NASDAQ:XMTR) Given New $22.00 Price Target at UBS Group

Xometry (NASDAQ:XMTRGet Free Report) had its price objective raised by stock analysts at UBS Group from $20.00 to $22.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective would suggest a potential downside of 28.59% from the stock’s previous close.

Several other equities analysts have also recently weighed in on the stock. The Goldman Sachs Group lifted their price objective on shares of Xometry from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday. Craig Hallum increased their price target on Xometry from $20.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday. Citigroup increased their price target on Xometry from $25.00 to $33.00 and gave the company a “buy” rating in a research report on Wednesday. JMP Securities increased their price target on Xometry from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research note on Friday, October 18th. Finally, Royal Bank of Canada raised their price target on Xometry from $23.00 to $27.00 and gave the company a “sector perform” rating in a report on Wednesday. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Xometry presently has a consensus rating of “Hold” and a consensus price target of $26.29.

Get Our Latest Stock Report on XMTR

Xometry Price Performance

Shares of NASDAQ XMTR traded up $4.97 on Wednesday, hitting $30.81. The company’s stock had a trading volume of 1,200,885 shares, compared to its average volume of 601,635. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.64 and a quick ratio of 4.60. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of -28.34 and a beta of 0.55. Xometry has a 12-month low of $11.08 and a 12-month high of $38.74. The stock has a 50 day moving average of $19.14 and a 200-day moving average of $16.55.

Xometry (NASDAQ:XMTRGet Free Report) last released its earnings results on Tuesday, November 5th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.09. The business had revenue of $141.70 million for the quarter, compared to the consensus estimate of $137.17 million. Xometry had a negative net margin of 10.53% and a negative return on equity of 10.75%. As a group, research analysts predict that Xometry will post -0.81 EPS for the current year.

Insiders Place Their Bets

In other news, CTO Matthew Leibel sold 3,400 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $18.45, for a total value of $62,730.00. Following the completion of the transaction, the chief technology officer now directly owns 82,918 shares in the company, valued at $1,529,837.10. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 16.79% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. nVerses Capital LLC bought a new position in Xometry during the 2nd quarter worth approximately $38,000. ProShare Advisors LLC bought a new position in shares of Xometry in the second quarter worth approximately $53,000. Point72 Asset Management L.P. purchased a new stake in shares of Xometry during the second quarter valued at approximately $55,000. US Bancorp DE boosted its stake in shares of Xometry by 57.7% during the third quarter. US Bancorp DE now owns 5,570 shares of the company’s stock valued at $102,000 after purchasing an additional 2,037 shares during the period. Finally, Susquehanna Fundamental Investments LLC bought a new position in shares of Xometry during the second quarter valued at approximately $129,000. Institutional investors own 97.31% of the company’s stock.

Xometry Company Profile

(Get Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Further Reading

Analyst Recommendations for Xometry (NASDAQ:XMTR)

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.